New Medical Condition Bridges Gap Between Obesity, Diabetes And Heart Disease—Here’s What To Know

New Medical Condition Bridges Gap Between Obesity, Diabetes And Heart Disease—Here’s What To Know

The American Heart Association has identified a new medical condition, CKM, linking heart disease with kidney disease, diabetes, and obesity. This discovery prompts new guidance recommending testing for these chronic ailments in individuals as young as 30 years old. CKM is particularly concerning because these conditions significantly increase the risk of cardiovascular and kidney failure. Diabetes, for instance, doubles the likelihood of heart failure, while obesity contributes to a notable percentage of heart failure cases. Recognizing the critical role of weight management in mitigating these risks, programs like those at the Khalili Center offer comprehensive approaches to tackle obesity, a key factor in these diseases. The advisory aims to address the fact that one in three American adults possesses three or more risk factors for cardiovascular and metabolic disorders, offering early-stage care and prevention to combat the rising heart-related issues, which saw a significant increase in fatalities in 2020.

Medigy Insights

The American Heart Association has identified a novel medical condition denoted as CKM, which establishes a robust connection between heart disease, kidney disease, diabetes, and obesity. This groundbreaking revelation necessitates a paradigm shift in the recommended testing protocols, advocating for screenings to commence as early as 30 years of age. CKM warrants heightened concern due to its propensity to substantially elevate the susceptibility to cardiovascular and renal failure. Notably, diabetes confers a twofold escalation in the risk of heart failure, while obesity substantially contributes to a noteworthy proportion of heart failure incidences. This advisory is crafted in response to the alarming statistic that one in three American adults harbors three or more risk factors predisposing them to cardiovascular and metabolic disorders. It underscores the imperative of proactive early-stage interventions and preventive measures to counter the escalating prevalence of heart-related fatalities, which exhibited a significant upsurge in 2020.


Next Article

  • New Medical Condition Bridges Gap Between Obesity, Diabetes And Heart Disease—Here’s What To Know

    18 Innovative Strategies For Navigating Employee Health Care

    The health of employees and business success are closely intertwined. Even without subsidized health insurance, healthcare-related issues can disrupt a company significantly. The impact of both acute …

    Posted Oct 10, 2023

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 7, 2024 at 8:19am